HIIFS
IPXL

Harel Insurance Investments & Financial Services’s Impax Laboratories, Inc. IPXL Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,000
Closed -$16K – 445
2017
Q2 		$16K Hold
1,000
– – ﹤0.01% 367
2017
Q1 		$13K Hold
1,000
– – ﹤0.01% 371
2016
Q4 		$13K Hold
1,000
– – ﹤0.01% 291
2016
Q3 		$24K Buy
+1,000
New +$26.9K ﹤0.01% 289

Other funds holding IPXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Harel Insurance Investments & Financial Services's IPXL Position: Q3 2017 in Review

Harel Insurance Investments & Financial Services sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 1,000 shares — an estimated $16K sold.

Harel Insurance Investments & Financial Services first reported a position in IPXL in Q3 2016 and held it in 4 quarters. The position peaked at $24K in Q3 2016. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

  • Harel Insurance Investments & Financial Services reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,000 Impax Laboratories, Inc. shares in Q3 2017, an estimated $16K.
  • Harel Insurance Investments & Financial Services first reported a position in Impax Laboratories, Inc. in Q3 2016 and held it in 4 quarters.
  • Harel Insurance Investments & Financial Services's Impax Laboratories, Inc. position peaked at $24K in Q3 2016.
  • 189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2017, filed 2 Nov 2017.